Compare BTEC vs. SBIO ETF performance
Comparing 2 ETFs | Performance |
BTEC SBIO |
Comparison analysis iShares Nasdaq US Biotechnology UCITS ETF (BTEC) does not belong to any segment. (SBIO) does not belong to any segment. BTEC invests in these top 3 sectors: Health Care, Other and Unavailable. BTEC’s top underlying securities are GILEAD SCIENCES (9.10%), VERTEX PHARMACEUTICALS (9.00%) and AMGEN-T (8.15%). The table below shows the full side-by-side ETF comparison of BTEC and SBIO, with detailed data on performance, flows, liquidity, exposure to individual stocks, segments, sectors, and geographies, helping you select the best ETFs. |
BTEC iShares Nasdaq US Biotechnology UCITS ETF - USDThis ETF provides exposure to US Equities Share class Acc USD ISIN IE00BYXG2H39 |
|---|
Product Type | - | - | ||
Strategy | - | - | ||
NAV | $8.33 | - | ||
AuM | - | - | ||
Total AuM of fund | €820M | |||
Base currency | ||||
E/R | 0.35% | |||
Rating | Not rated | |||
Provider | ||||
Investment strategy | ||||
Dividend policy | Capitalization | - | ||
Tax optimisation | ||||
PEA | ||||
UK Reporting | ||||
Performance and flows | Perf. Flows | Perf. Flows | ||
1 month | - To view, create a free account | - To view, create a free account | ||
3 months | - | - | ||
1 year | - | - | ||
3 years | - | - | ||
5 years | - | - | ||
Month to date | - | - | ||
Quarter to date | - | - | ||
Year to date | - | - | ||
Volatility and risk | 1 year 3 years 5 years | 1 year 3 years 5 years | ||
Volatility | To view, create a free account | To view, create a free account | ||
Perf./Volatility | ||||
Max drawdown | ||||
Create a free Trackinsight Essentials account to unlock insights Access exclusive metrics and features to support your investment decisions. | ||||
Exposure | ||||
Countries | - | |||
Sectors or issuer types | - | |||
Number of holdings | 262 | - | ||
Weight of top 15 holdings | ||||
Top 15 holdings | GILEAD SCIENCES VERTEX PHARMACEUTICALS AMGEN-T REGENERON PHARMACEUTICALS ALNYLAM PHARMACEUTICALS INSMED BIOGEN INC US04016X1019 ILLUMINA UTD THERAPEUT INCYTE REVOLUTION MEDICINES INC MODERNA INC ROYALTY PHARMA MEDPACE HOLDINGS INC To view, create a free account | |||
Replication | ||||
Benchmark | ||||
Replication method | ||||
Replication model | ||||
Trackinsight replication rating | Not rated | |||
Tracking error (1Y) | ||||
Tracking difference (1Y) | ||||
Sustainability | ||||
ESG Consensus® |  |  | ||
SDG |
Frequently asked questions about BTEC and SBIO
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
